Humanities
Skip to main content Skip to main navigation menu Skip to site footer
  • Register
  • Login
  • Menu
  • Home
  • Current
  • Archives
  • Announcements
  • About
    • About the Journal
    • Submissions
    • Editorial Team
    • Privacy Statement
    • Contact
  • Register
  • Login

Journal of Education, Health and Sport

Lifestyle and Atrial Fibrillation: The Role of Obesity, Exercise, and Weight Loss in Risk Reduction and Rhythm Management
  • Home
  • /
  • Lifestyle and Atrial Fibrillation: The Role of Obesity, Exercise, and Weight Loss in Risk Reduction and Rhythm Management
  1. Home /
  2. Archives /
  3. Vol. 82 (2025) /
  4. Medical Sciences

Lifestyle and Atrial Fibrillation: The Role of Obesity, Exercise, and Weight Loss in Risk Reduction and Rhythm Management

Authors

  • Szymon Pucyło Miedzylesie Specialist Hospital in Warsaw, Bursztynowa 04-749 Warsaw, Poland https://orcid.org/0009-0007-0143-7115
  • Martyna Skweres National Medical Institute of the Ministry of the Interior and Administration, Wołoska 137, 02-507 Warsaw, Poland https://orcid.org/0009-0003-1228-7918

DOI:

https://doi.org/10.12775/JEHS.2025.82.60327

Keywords

atrial fibrillation, obesity, exercise, weight loss

Abstract

Introduction and puropse. Atrial fibrillation (AF) is the most common sustained arrhythmia worldwide, closely associated with rising obesity rates and sedentary lifestyles. This review evaluates the evidence linking obesity, physical activity, and weight reduction with AF development, progression, and management.

Material and methods. A comprehensive literature review was conducted using PubMed and Google Scholar, prioritizing randomized trials, meta-analyses, and recent studies published within the past eight years addressing obesity, physical activity, and weight loss in AF.

Brief description of the state of knowledge. Obesity is a major risk factor for atrial fibrillation, with each 5-unit BMI increase linked to a 28–30% rise in risk. Higher BMI is associated with increased AF incidence, faster progression, and recurrence rates up to 50% after ablation in severe obesity. Moderate physical activity contributes to lower risk of AF and improved rhythm control, while high-intensity endurance exercise may elevate AF risk, particularly in middle-aged men. Sustained weight loss of at least 10% significantly reduces AF burden, recurrence rates, and symptom severity. Bariatric surgery has been shown to decrease AF incidence in severely obese patients, and long-term weight stability enhances these benefits. Anticoagulant efficacy remains stable across BMI ranges, especially rivaroxaban, which shows favorable profiles in obese patients.

Conclusions. Current evidence supports the integration of lifestyle interventions such as targeted weight loss and individualized physical activity into AF management. These strategies offer significant benefits to AF risk, arrhythmia control, and overall outcomes, supporting routine implementation in clinical practice.

References

1. Na J, Garapati SS, Lador A. Obesity and Atrial Fibrillation: A Comprehensive Review. Methodist Debakey Cardiovasc J. 2025;21(2):35-43.

2. Lavie Carl J, Pandey A, Lau Dennis H, Alpert Martin A, Sanders P. Obesity and Atrial Fibrillation Prevalence, Pathogenesis, and Prognosis. JACC. 2017;70(16):2022-35.

3. Sha R, Baines O, Hayes A, Tompkins K, Kalla M, Holmes AP, et al. Impact of Obesity on Atrial Fibrillation Pathogenesis and Treatment Options. Journal of the American Heart Association. 2024;13(1):e032277.

4. Mishima RS, Verdicchio CV, Noubiap JJ, Ariyaratnam JP, Gallagher C, Jones D, et al. Self-reported physical activity and atrial fibrillation risk: A systematic review and meta-analysis. Heart Rhythm. 2021;18(4):520-8.

5. Zacher J, Filipovic K, Predel G, Schmidt T. Exercise and Atrial Fibrillation: The Dose Makes the Poison? A Narrative Review. Int J Sports Med. 2024;45(1):17-22.

6. Van Gelder IC, Rienstra M, Bunting KV, Casado-Arroyo R, Caso V, Crijns H, et al. 2024 ESC Guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J. 2024;45(36):3314-414.

7. Kichloo A, Marrufo I, Bhavsar V, Ghantasala P, Ejaz SH, Jamal S. The Impact of Obesity on Atrial Fibrillation Review: Prevalence, Pathophysiology, and Challenges in Management. Medical Research Archives. 2025;13(3).

8. Tabaja C, Younis A, Santageli P, Farwati M, Braghieri L, Nakagawa H, et al. Impact of obesity on catheter ablation of atrial fibrillation: Patient characteristics, procedural complications, outcomes, and quality of life. J Cardiovasc Electrophysiol. 2023;34(8):1648-57.

9. Lavie CJ, Pandey A, Lau DH, Alpert MA, Sanders P. Obesity and Atrial Fibrillation Prevalence, Pathogenesis, and Prognosis: Effects of Weight Loss and Exercise. J Am Coll Cardiol. 2017;70(16):2022-35.

10. Linz D, Mahfoud F, Schotten U, Ukena C, Neuberger HR, Wirth K, et al. Renal sympathetic denervation suppresses postapneic blood pressure rises and atrial fibrillation in a model for sleep apnea. Hypertension. 2012;60(1):172-8.

11. Mahajan R, Lau DH, Brooks AG, Shipp NJ, Manavis J, Wood JP, et al. Electrophysiological, Electroanatomical, and Structural Remodeling of the Atria as Consequences of Sustained Obesity. J Am Coll Cardiol. 2015;66(1):1-11.

12. Sha R, Baines O, Hayes A, Tompkins K, Kalla M, Holmes AP, et al. Impact of Obesity on Atrial Fibrillation Pathogenesis and Treatment Options. J Am Heart Assoc. 2024;13(1):e032277.

13. Shu H, Cheng J, Li N, Zhang Z, Nie J, Peng Y, et al. Obesity and atrial fibrillation: a narrative review from arrhythmogenic mechanisms to clinical significance. Cardiovasc Diabetol. 2023;22(1):192.

14. Sandhu RK, Ezekowitz J, Andersson U, Alexander JH, Granger CB, Halvorsen S, et al. The 'obesity paradox' in atrial fibrillation: observations from the ARISTOTLE (Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation) trial. Eur Heart J. 2016;37(38):2869-78.

15. Sandhu RK, Ezekowitz JA, Hijazi Z, Westerbergh J, Aulin J, Alexander JH, et al. Obesity paradox on outcome in atrial fibrillation maintained even considering the prognostic influence of biomarkers: insights from the ARISTOTLE trial. Open Heart. 2018;5(2):e000908.

16. Grymonprez M, Capiau A, De Backer TL, Steurbaut S, Boussery K, Lahousse L. The impact of underweight and obesity on outcomes in anticoagulated patients with atrial fibrillation: A systematic review and meta-analysis on the obesity paradox. Clin Cardiol. 2021;44(5):599-608.

17. Pandey A, Gersh BJ, McGuire DK, Shrader P, Thomas L, Kowey PR, et al. Association of Body Mass Index With Care and Outcomes in Patients With Atrial Fibrillation: Results From the ORBIT-AF Registry. JACC Clin Electrophysiol. 2016;2(3):355-63.

18. Overvad TF, Rasmussen LH, Skjøth F, Overvad K, Lip GY, Larsen TB. Body mass index and adverse events in patients with incident atrial fibrillation. Am J Med. 2013;126(7):640.e9-17.

19. Boriani G, Ruff CT, Kuder JF, Shi M, Lanz HJ, Rutman H, et al. Relationship between body mass index and outcomes in patients with atrial fibrillation treated with edoxaban or warfarin in the ENGAGE AF-TIMI 48 trial. Eur Heart J. 2019;40(19):1541-50.

20. Zhu W, Wan R, Liu F, Hu J, Huang L, Li J, et al. Relation of Body Mass Index With Adverse Outcomes Among Patients With Atrial Fibrillation: A Meta-Analysis and Systematic Review. J Am Heart Assoc. 2016;5(9).

21. Pathak RK, Middeldorp ME, Lau DH, Mehta AB, Mahajan R, Twomey D, et al. Aggressive risk factor reduction study for atrial fibrillation and implications for the outcome of ablation: the ARREST-AF cohort study. J Am Coll Cardiol. 2014;64(21):2222-31.

22. Proietti M, Guiducci E, Cheli P, Lip GY. Is There an Obesity Paradox for Outcomes in Atrial Fibrillation? A Systematic Review and Meta-Analysis of Non-Vitamin K Antagonist Oral Anticoagulant Trials. Stroke. 2017;48(4):857-66.

23. Di Benedetto L, Michels G, Luben R, Khaw K-T, Pfister R. Individual and combined impact of lifestyle factors on atrial fibrillation in apparently healthy men and women: The EPIC-Norfolk prospective population study. European Journal of Preventive Cardiology. 2020;25(13):1374-83.

24. Chatterjee NA, Giulianini F, Geelhoed B, Lunetta KL, Misialek JR, Niemeijer MN, et al. Genetic Obesity and the Risk of Atrial Fibrillation: Causal Estimates from Mendelian Randomization. Circulation. 2017;135(8):741-54.

25. Asad Z, Abbas M, Javed I, Korantzopoulos P, Stavrakis S. Obesity is associated with incident atrial fibrillation independent of gender: A meta-analysis. J Cardiovasc Electrophysiol. 2018;29(5):725-32.

26. Folli F, Centofanti L, Magnani S, Tagliabue E, Bignotto M, La Sala L, et al. Obesity effect on newly diagnosed and recurrent post-ablation atrial fibrillation: a systematic review and meta-analysis. J Endocrinol Invest. 2024;47(5):1051-66.

27. Aymond JD, Sanchez AM, Castine MR, Bernard ML, Khatib S, Hiltbold AE, et al. Dual vs Single Cardioversion of Atrial Fibrillation in Patients With Obesity: A Randomized Clinical Trial. JAMA Cardiol. 2024;9(7):641-8.

28. Zhuo X, Wang J, Shao L. Comparing the Clinical Outcomes Observed with Rivaroxaban Versus Warfarin for the Management of Obese Patients with Non-valvular Atrial Fibrillation: a Systematic Review and Meta-analysis. Cardiovasc Drugs Ther. 2024;38(1):79-89.

29. Patel SM, Braunwald E, Steffel J, Boriani G, Palazzolo MG, Antman EM, et al. Efficacy and Safety of Non-Vitamin-K Antagonist Oral Anticoagulants Versus Warfarin Across the Spectrum of Body Mass Index and Body Weight: An Individual Patient Data Meta-Analysis of 4 Randomized Clinical Trials of Patients With Atrial Fibrillation. Circulation. 2024;149(12):932-43.

30. Gessler N, Willems S, Steven D, Aberle J, Akbulak RO, Gosau N, et al. Supervised Obesity Reduction Trial for AF ablation patients: results from the SORT-AF trial. Europace. 2021;23(10):1548-58.

31. Kherlopian A, Weinshel S, Madias C, Estes NAM, 3rd. Exercise and Athletic Activity in Atrial Fibrillation. Card Electrophysiol Clin. 2021;13(1):173-82.

32. Morseth B, Løchen ML, Ariansen I, Myrstad M, Thelle DS. The ambiguity of physical activity, exercise and atrial fibrillation. Eur J Prev Cardiol. 2018;25(6):624-36.

33. Elliott AD, Verdicchio CV, Mahajan R, Middeldorp ME, Gallagher C, Mishima RS, et al. An Exercise and Physical Activity Program in Patients With Atrial Fibrillation: The ACTIVE-AF Randomized Controlled Trial. JACC Clin Electrophysiol. 2023;9(4):455-65.

34. Pathak RK, Elliott A, Middeldorp ME, Meredith M, Mehta AB, Mahajan R, et al. Impact of CARDIOrespiratory FITness on Arrhythmia Recurrence in Obese Individuals With Atrial Fibrillation: The CARDIO-FIT Study. J Am Coll Cardiol. 2015;66(9):985-96.

35. Kunutsor SK, Seidu S, Mäkikallio TH, Dey RS, Laukkanen JA. Physical activity and risk of atrial fibrillation in the general population: meta-analysis of 23 cohort studies involving about 2 million participants. Eur J Epidemiol. 2021;36(3):259-74.

36. Valenzuela PL, Morales JS, Santos-Lozano A, Saco-Ledo G, Diaz-Gonzalez L, Boraita A, et al. What do we really know about the association between physical activity, sports, and atrial fibrillation? A systematic review and meta-analysis from unbiased studies. Eur J Prev Cardiol. 2022;29(4):e143-e8.

37. Aldaas OM, Lupercio F, Han FT, Hoffmayer KS, Krummen D, Ho G, et al. Meta-analysis of Effect of Modest (≥10%) Weight Loss in Management of Overweight and Obese Patients With Atrial Fibrillation. Am J Cardiol. 2019;124(10):1568-74.

38. Pathak RK, Middeldorp ME, Meredith M, Mehta AB, Mahajan R, Wong CX, et al. Long-Term Effect of Goal-Directed Weight Management in an Atrial Fibrillation Cohort: A Long-Term Follow-Up Study (LEGACY). J Am Coll Cardiol. 2015;65(20):2159-69.

39. Akhtar KH, Jafry AH, Beard C, Nasir YM, Agarwal S, Khan J, et al. The effect of weight loss on recurrence of atrial fibrillation after catheter ablation: A systematic review and meta-analysis. J Cardiovasc Electrophysiol. 2023;34(12):2514-26.

40. Pontiroli AE, Centofanti L, Le Roux CW, Magnani S, Tagliabue E, Folli F. Effect of Prolonged and Substantial Weight Loss on Incident Atrial Fibrillation: A Systematic Review and Meta-Analysis. Nutrients. 2023;15(4).

41. Chokesuwattanaskul R, Thongprayoon C, Bathini T, Sharma K, Watthanasuntorn K, Lertjitbanjong P, et al. Incident atrial fibrillation in patients undergoing bariatric surgery: a systematic review and meta-analysis. Intern Med J. 2020;50(7):810-7.

42. de Oliveira Almeida G, Nienkötter TF, Balieiro CCA, Pasqualotto E, Cintra JB, Carvalho HCP, et al. Cardiovascular Benefits of GLP-1 Receptor Agonists in Patients Living with Obesity or Overweight: A Meta-analysis of Randomized Controlled Trials. Am J Cardiovasc Drugs. 2024;24(4):509-21.

43. Saglietto A, Falasconi G, Penela D, Francia P, Sau A, Ng FS, et al. Glucagon-like peptide-1 receptor agonist semaglutide reduces atrial fibrillation incidence: A systematic review and meta-analysis. Eur J Clin Invest. 2024;54(12):e14292.

44. Rossello X, Ramallal R, Romaguera D, Alonso-Gómez Á M, Alonso A, Tojal-Sierra L, et al. Effect of an intensive lifestyle intervention on the structural and functional substrate for atrial fibrillation in people with metabolic syndrome. Eur J Prev Cardiol. 2024;31(5):629-39.

45. LOSE-AF: Can Weight Loss Help Patients With Atrial Fibrillation? (LOSE-AF) [Internet]. ClinicalTrials.gov Identifier: NCT03713775. Bethesda (MD): National Library of Medicine (US); 2018 Oct 18 – [updated 2023 Oct 6; cited 2025 Apr 5]. Available from: https://clinicaltrials.gov/ct2/show/NCT03713775.

46. A Behavioural Weight Loss Intervention Delivered in Cardiac Rehabilitation for Patients With Atrial Fibrillation and Obesity (BeWEL IN CR-AF) [Internet]. ClinicalTrials.gov Identifier: NCT05600829. Bethesda (MD): National Library of Medicine (US); 2022 Nov 9 – [updated 2023 Dec 15; cited 2025 Apr 5]. Available from: https://clinicaltrials.gov/ct2/show/NCT05600829.

47. Effect of Complex Weight-reducing Interventions on Rhythm Control in Obese Subjects With Atrial Fibrillation (HOBIT-FS) [Internet]. ClinicalTrials.gov Identifier: NCT04560387. Bethesda (MD): National Library of Medicine (US); 2020 Sep 21 – [updated 2023 Oct 5; cited 2025 Apr 5]. Available from: https://clinicaltrials.gov/ct2/show/NCT04560387.

48. Exercise-based Cardiac Rehabilitation for Atrial Fibrillation (ExCR-AF) [Internet]. ClinicalTrials.gov Identifier: NCT06401148. Bethesda (MD): National Library of Medicine (US); 2023 Nov 6 – [updated 2024 Jan 23; cited 2025 Apr 5]. Available from: https://clinicaltrials.gov/ct2/show/NCT06401148.

49. Exercise Training in Patients With Persistent or Permanent Atrial Fibrillation (Exercise-AF) [Internet]. ClinicalTrials.gov Identifier: NCT03397602. Bethesda (MD): National Library of Medicine (US); 2018 Jan 18 – [updated 2023 Sep 27; cited 2025 Apr 5]. Available from: https://clinicaltrials.gov/ct2/show/NCT03397602.

50. Wass SY, Barnard J, Kim HS, Sun H, Telfer W, Schilling T, et al. Upstream targeting for the prevention of atrial fibrillation: Targeting Risk Interventions and Metformin for Atrial Fibrillation (TRIM-AF)-rationale and study design. J Interv Card Electrophysiol. 2025;68(1):9-19.

Journal of Education, Health and Sport

Downloads

  • PDF

Published

2025-06-09

How to Cite

1.
PUCYŁO, Szymon and SKWERES, Martyna. Lifestyle and Atrial Fibrillation: The Role of Obesity, Exercise, and Weight Loss in Risk Reduction and Rhythm Management. Journal of Education, Health and Sport. Online. 9 June 2025. Vol. 82, p. 60327. [Accessed 11 July 2025]. DOI 10.12775/JEHS.2025.82.60327.
  • ISO 690
  • ACM
  • ACS
  • APA
  • ABNT
  • Chicago
  • Harvard
  • IEEE
  • MLA
  • Turabian
  • Vancouver
Download Citation
  • Endnote/Zotero/Mendeley (RIS)
  • BibTeX

Issue

Vol. 82 (2025)

Section

Medical Sciences

License

Copyright (c) 2025 Szymon Pucyło, Martyna Skweres

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

The periodical offers access to content in the Open Access system under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0

Stats

Number of views and downloads: 189
Number of citations: 0

Search

Search

Browse

  • Browse Author Index
  • Issue archive

User

User

Current Issue

  • Atom logo
  • RSS2 logo
  • RSS1 logo

Information

  • For Readers
  • For Authors
  • For Librarians

Newsletter

Subscribe Unsubscribe

Tags

Search using one of provided tags:

atrial fibrillation, obesity, exercise, weight loss
Up

Akademicka Platforma Czasopism

Najlepsze czasopisma naukowe i akademickie w jednym miejscu

apcz.umk.pl

Partners

  • Akademia Ignatianum w Krakowie
  • Akademickie Towarzystwo Andragogiczne
  • Fundacja Copernicus na rzecz Rozwoju Badań Naukowych
  • Instytut Historii im. Tadeusza Manteuffla Polskiej Akademii Nauk
  • Instytut Kultur Śródziemnomorskich i Orientalnych PAN
  • Instytut Tomistyczny
  • Karmelitański Instytut Duchowości w Krakowie
  • Ministerstwo Kultury i Dziedzictwa Narodowego
  • Państwowa Akademia Nauk Stosowanych w Krośnie
  • Państwowa Akademia Nauk Stosowanych we Włocławku
  • Państwowa Wyższa Szkoła Zawodowa im. Stanisława Pigonia w Krośnie
  • Polska Fundacja Przemysłu Kosmicznego
  • Polskie Towarzystwo Ekonomiczne
  • Polskie Towarzystwo Ludoznawcze
  • Towarzystwo Miłośników Torunia
  • Towarzystwo Naukowe w Toruniu
  • Uniwersytet im. Adama Mickiewicza w Poznaniu
  • Uniwersytet Komisji Edukacji Narodowej w Krakowie
  • Uniwersytet Mikołaja Kopernika
  • Uniwersytet w Białymstoku
  • Uniwersytet Warszawski
  • Wojewódzka Biblioteka Publiczna - Książnica Kopernikańska
  • Wyższe Seminarium Duchowne w Pelplinie / Wydawnictwo Diecezjalne „Bernardinum" w Pelplinie

© 2021- Nicolaus Copernicus University Accessibility statement Shop